The effect of plaque retention on cyclosporine-induced gingival overgrowth in rats.
The purpose of this study was to examine the role of plaque retention on cyclosporine A (CsA)-induced gingival overgrowth. Forty-five male Sprague-Dawley rats, 15 for each of three CsA dosage conditions, were unilaterally ligated around the first mandibular molar (plaque retention). The silk ligature was left in place for 6 weeks. Contralateral first molars served as unligated controls. The daily dosage of CsA, administered by gastric feeding, was 0, 3, or 10 mg/kg body weight. Stone models from biweekly impressions of the molar sites were used to investigate development of gingival overgrowth. Rats were sacrificed at 6 weeks for histopathological and histometric examination of the molar sites. Gingival overgrowth was significantly increased in sites with higher CsA dosage, longer treatment duration, and ligation. Gingival overgrowth was enhanced in ligated sites regardless of CsA dosage. However, the odds ratio of ligated over unligated sites for gingival overgrowth increased with increasing CsA dosage. The histopathological and histometric examination revealed significantly increased gingival volume in ligated sites in CsA-treated animals. The tissue enlargement included both the epithelium and the connective tissue; however, the epithelium to connective tissue ratio remained unaltered. Within limitations of the study, we suggest that plaque retention magnifies CsA-induced gingival overgrowth; thus, dental plaque appears to be a cofactor in the development of CsA-induced gingival overgrowth.
Fu
E
E
Department of Periodontology, School of Dentistry, National Defense Medical Center, Taipei, Taiwan, ROC.
Nieh
S
S
Wikesjö
U M
UM
D000704:Analysis of Variance; D000818:Animals; D016572:Cyclosporine / Q000633:toxicity*; D003773:Dental Plaque / Q000150:complications*; D005885:Gingival Hyperplasia / Q000139:chemically induced / Q000209:etiology*; D007166:Immunosuppressive Agents / Q000633:toxicity*; D008026:Ligation; D016014:Linear Models; D008297:Male; D016017:Odds Ratio; D051381:Rats; D017207:Rats, Sprague-Dawley
D007166:Immunosuppressive Agents; D016572:Cyclosporine